Clinical Focus

  • Ophthalmology

Academic Appointments

Professional Education

  • Residency:Montefiore Medical Center/Albert Einstein COM (2013) NY
  • Internship:Howard University Hospital (2010) DC
  • Medical Education:Lousiana State University (2009) LA
  • Bachelor of Arts, University of Pennsylvania (2005)
  • Doctor of Medicine, Louisiana State Univ Medical Center (2009)

Stanford Advisors


Journal Articles

  • Corneal collagen crosslinking in refractive surgery CURRENT OPINION IN OPHTHALMOLOGY Cheema, A. S., Mozayan, A., Channa, P. 2012; 23 (4): 251-256


    To describe the development and uses of corneal collagen crosslinking (CXL) in association with keratorefractive procedures as well as in the treatment of progressive keratoconus and progressive postlaser in-situ keratomileusis (post-LASIK) keratectasia.CXL has been shown to be effective in slowing, halting or reversing progressive ectasia in both keratoconus and progressive post-LASIK keratectasia by means of corneal stiffening. Thus, it is the only treatment option currently available that addresses the underlying progression of ectactic conditions. Combining CXL with keratorefractive procedures, such as intrastromal corneal ring segment implantation and photorefractive keratectomy, is a promising therapeutic alternative to penetrating keratoplasty or lamellar keratoplasty that in many cases can improve visual acuity, stabilize ectasia, and delay or even prevent the need for more invasive procedures.The stiffening effect of CXL has made it a promising alternative in the ophthalmologist's armamentarium for treatment of progressive keratoconus and progressive post-LASIK keratectasia. Future studies are needed to determine the long-term stability of CXL, as well as to address possible complications.

    View details for DOI 10.1097/ICU.0b013e3283543cbd

    View details for Web of Science ID 000307945300004

    View details for PubMedID 22569468

Stanford Medicine Resources: